Bruce Motyka

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Toll Like Receptor

Immune Response

Hepatitis B Virus

Top Venues

Human vaccines & immunotherapeutics

RSC chemical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Gour Chand Daskhan, Bruce Motyka, Roger Bascom, Hanh Thuc Tran, Kesheng Tao, Lori J West, Christopher W Cairo
Extending the in vivo persistence of synthetic glycoconjugates using a serum-protein binder. RSC chemical biology 3 (10) (2022)
Sergio Gil-Manso, Iria Miguens Blanco, Bruce Motyka, Anne Halpin, Rocío López-Esteban, Verónica Astrid Pérez-Fernández, Diego Carbonell Muñoz, Luis Andrés López-Fernández, Lori J West, Rafael Correa-Rocha, Marjorie Pion
ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2. Virulence 13 (1) (2022)
Allan Ma, Bruce Motyka, Klaus Gutfreund, Yuenian Eric Shi, Rajan George
A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B. Human vaccines & immunotherapeutics 16 (4) (2019)
Rajan George, Allan Ma, Bruce Motyka, Yuenian Eric Shi, Qiang Liu, Philip Griebel
A dendritic cell-targeted chimeric hepatitis B virus immunotherapeutic vaccine induces both cellular and humoral immune responses in vivo. Human vaccines & immunotherapeutics 16 (4) (2019)